Additionally, no significant differences were found between SU and RNU in univariate and multivariate analyses in terms of CSS or any other oncologic outcomes, despite an overall trend toward worse outcomes after SU ( 19 , 34 ).
← all excerpts
Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes.
1
—
—